A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer.
Tanaka H, Taima K, Morimoto T, Tanaka Y, Itoga M, Nakamura K, Hayashi A, Kumagai M, Yasugahira H, Mikuniya M, Okudera K, Takanashi S, Tasaka S.
Tanaka H, et al. Among authors: hayashi a.
BMC Cancer. 2017 Oct 16;17(1):683. doi: 10.1186/s12885-017-3684-8.
BMC Cancer. 2017.
PMID: 29037236
Free PMC article.
Clinical Trial.